Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for improving urination disorders caused by BPH and method for making the same

A technology for urination disorder and composition, applied in the field of pharmaceutical compositions for urination disorder, can solve problems such as unsatisfactory, and achieve the effects of obvious efficacy, improvement of subjective and objective symptoms, and anti-aging immune function.

Inactive Publication Date: 2008-03-05
BEIJING WONNER BIOTECH LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The mechanism of traditional Chinese medicine compound preparations (such as Longbishu, etc.) to treat BPH is multi-target and multi-directional treatment. Its advantage is that it can regulate the patient as a whole and is safe. The voiding disorder is basically unsatisfactory, usually after 20 to 30 days of taking the medicine, it is difficult for the patient to feel that the voiding disorder has been significantly relieved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for improving urination disorders caused by BPH and method for making the same
  • Pharmaceutical composition for improving urination disorders caused by BPH and method for making the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Referring to accompanying drawing 1, 27 kilograms of ginseng (conforming to the provisions of "The Pharmacopoeia of the People's Republic of China") are broken and decocted with 70% ethanol solution, separated and purified by chromatography, and dried to obtain 1.35 kilograms of extract; 54 kilograms of ginkgo are broken and decocted with water , filtered, concentrated, and dried to obtain 3.78 kg of water-extracted dry extract; the extract obtained in the above steps and water-extracted dry extract were mixed and pulverized, and passed through a 80-mesh sieve to obtain the extract of the present invention.

Embodiment 2

[0048] Repeat the steps of Example 1, the difference is that the ginseng is changed to American ginseng (according to the provisions of "The Pharmacopoeia of the People's Republic of China"), the dosage is changed to 13.5 kilograms, and the ginkgo is still 54 kilograms. Other operating steps are the same as in Example 1, and 0.68 kilograms of American ginseng are obtained The extract (wherein the ginsenoside content is 30%) and 3.78 kilograms of ginkgo dry extract are mixed and pulverized.

Embodiment 3

[0050] Referring to accompanying drawing 2, select 9 kilograms of ginseng (or 4.5 kilograms of American ginseng) and 18 kilograms of ginkgo to be broken respectively and decoct together with an aqueous solution of 8 times the amount, decoct for 1 hour after boiling for the first time, filter, and leave standstill; After boiling for 45 minutes, filter and stand still; mix the two decoctions, concentrate at low temperature, and spray dry to obtain the extract of the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses one kind of medicine composition prepared with ginseng or American ginseng, ginkgo and other isogenous medicine and food botanic materials and through extraction in alcohol solution or water, concentration of the extract, drying and other steps. The medicine composition can eliminate BPH caused urinary dysfunction, and has no toxicity and less side effects. It may be used in preparing medicine and health food for eliminating BPH caused urinary dysfunction.

Description

technical field [0001] The invention relates to a pharmaceutical composition capable of improving urination disorder caused by benign prostatic hyperplasia (BPH), which can be used as medicine and health food. [0002] The present invention also relates to two preparation methods of the pharmaceutical composition for improving urination disorder caused by BPH. Background technique [0003] Urination disorder caused by benign prostatic hyperplasia (BPH) is a common and frequently-occurring disease that endangers and troubles the health of middle-aged and elderly men, especially in recent years with the increase of the elderly population, its incidence has been increasing. Taking the United States as an example, according to statistics, almost 1 / 3 of American adult men suffer from benign prostatic hyperplasia. In China, the incidence of benign prostatic hyperplasia also has a tendency to increase rapidly. According to the survey, the incidence of Chinese men over 41 years old...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/258A61K9/14A61K9/20A61K9/48A61P13/08A23L1/29A23L33/00
Inventor 张作光
Owner BEIJING WONNER BIOTECH LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products